Ikena Total Cash From Operating Activities from 2010 to 2024
| IKNA Stock | USD 1.36 0.03 2.26% |
Total Cash From Operating Activities | First Reported 2010-12-31 | Previous Quarter -79.7 M | Current Value -75.8 M | Quarterly Volatility 34.1 M |
Check Ikena Oncology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ikena main balance sheet or income statement drivers, such as Interest Expense of 2.6 M, Depreciation And Amortization of 628.8 K or Selling General Administrative of 17.9 M, as well as many exotic indicators such as Price To Sales Ratio of 8.53, Dividend Yield of 0.0 or PTB Ratio of 0.51. Ikena financial statements analysis is a perfect complement when working with Ikena Oncology Valuation or Volatility modules.
Ikena | Total Cash From Operating Activities |
Latest Ikena Oncology's Total Cash From Operating Activities Growth Pattern
Below is the plot of the Total Cash From Operating Activities of Ikena Oncology over the last few years. It is Ikena Oncology's Total Cash From Operating Activities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ikena Oncology's overall financial position and show how it may be relating to other accounts over time.
| Total Cash From Operating Activities | 10 Years Trend |
|
Total Cash From Operating Activities |
| Timeline |
Ikena Total Cash From Operating Activities Regression Statistics
| Arithmetic Mean | (25,615,390) | |
| Geometric Mean | 22,463,421 | |
| Coefficient Of Variation | (133.28) | |
| Mean Deviation | 26,614,520 | |
| Median | (11,608,000) | |
| Standard Deviation | 34,141,129 | |
| Sample Variance | 1165.6T | |
| Range | 127.7M | |
| R-Value | (0.62) | |
| Mean Square Error | 773.3T | |
| R-Squared | 0.38 | |
| Significance | 0.01 | |
| Slope | (4,730,393) | |
| Total Sum of Squares | 16318.6T |
Ikena Total Cash From Operating Activities History
About Ikena Oncology Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Ikena Oncology income statement, its balance sheet, and the statement of cash flows. Ikena Oncology investors use historical funamental indicators, such as Ikena Oncology's Total Cash From Operating Activities, to determine how well the company is positioned to perform in the future. Although Ikena Oncology investors may use each financial statement separately, they are all related. The changes in Ikena Oncology's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Ikena Oncology's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Ikena Oncology Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Ikena Oncology. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Cash From Operating Activities | -79.7 M | -75.8 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ikena Oncology in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ikena Oncology's short interest history, or implied volatility extrapolated from Ikena Oncology options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Ikena Oncology Correlation against competitors. For information on how to trade Ikena Stock refer to our How to Trade Ikena Stock guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Ikena Stock analysis
When running Ikena Oncology's price analysis, check to measure Ikena Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ikena Oncology is operating at the current time. Most of Ikena Oncology's value examination focuses on studying past and present price action to predict the probability of Ikena Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ikena Oncology's price. Additionally, you may evaluate how the addition of Ikena Oncology to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
Is Ikena Oncology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ikena Oncology. If investors know Ikena will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ikena Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.63) | Revenue Per Share 0.219 | Quarterly Revenue Growth (0.88) | Return On Assets (0.26) | Return On Equity (0.43) |
The market value of Ikena Oncology is measured differently than its book value, which is the value of Ikena that is recorded on the company's balance sheet. Investors also form their own opinion of Ikena Oncology's value that differs from its market value or its book value, called intrinsic value, which is Ikena Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ikena Oncology's market value can be influenced by many factors that don't directly affect Ikena Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ikena Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ikena Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ikena Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.